Literature DB >> 23358098

Emotional sequelae among survivors of critical illness: a long-term retrospective study.

Michał Kowalczyk1, Andrzej Nestorowicz, Anna Fijałkowska, Magdalena Kwiatosz-Muc.   

Abstract

CONTEXT: Treatment in an ICU can be stressful and traumatic for patients, and can lead to various physical, psychological and cognitive sequelae.
OBJECTIVES: The aim of the study was to assess the influence of the social, economic and working status of individuals in regard to long-term anxiety and depression among ICU convalescents.
DESIGN: Retrospective, cross-sectional, 5-year survey between 2005 and 2009.
SETTING: The general ICUs of two hospitals in Lublin (Poland): the Teaching Hospital, Medical University of Lublin and the District Hospital. PATIENTS: All adults surviving an ICU stay of more than 24 h were eligible. In December 2010, 533 questionnaires were sent to discharged ICU survivors, and 195 (36.6%) were returned. One hundred and eighty-six patients were enrolled in the study. Patients with brain injuries were excluded. MAIN OUTCOME MEASURES: The questionnaire consisted of the Hospital Anxiety and Depression Scale (HADS); questions defining social, economic and working status before and after intensive care stay, health status before intensive care stay, as well as questions about memories and readmissions to intensive care were included.
RESULTS: According to HADS, 34.4% patients had an anxiety disorder and 27.4% were depressed. There was a strong positive correlation between anxiety and depression (r = +0.726, P<0.001). Better material and housing conditions correlated with lower anxiety and depression rates. Acute Physiology and Chronic Health Evaluation II scores on admission positively correlated with both anxiety (r =+0.187; P=0.011) and depression (r = +0.239; P=0.001). A negative correlation between health status before intensive care admission and HADS scores was observed (anxiety rs = -0.193; P=0.008; depression rs = -0.227; P=0.002); better health resulted in less anxiety and depression disorders.
CONCLUSION: Adverse social and economic status is associated with higher rates of anxiety and depression following ICU stay.

Entities:  

Mesh:

Year:  2013        PMID: 23358098     DOI: 10.1097/EJA.0b013e32835dcc45

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  6 in total

1.  What's new on the post-ICU burden for patients and relatives?

Authors:  Christina Jones
Journal:  Intensive Care Med       Date:  2013-07-16       Impact factor: 17.440

Review 2.  Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis.

Authors:  Sina Nikayin; Anahita Rabiee; Mohamed D Hashem; Minxuan Huang; O Joseph Bienvenu; Alison E Turnbull; Dale M Needham
Journal:  Gen Hosp Psychiatry       Date:  2016-08-28       Impact factor: 3.238

Review 3.  Instrumental Activities of Daily Living after Critical Illness: A Systematic Review.

Authors:  Ramona O Hopkins; Mary R Suchyta; Biren B Kamdar; Emily Darowski; James C Jackson; Dale M Needham
Journal:  Ann Am Thorac Soc       Date:  2017-08

4.  Depression following critical illness: Analysis of incidence and risk factors.

Authors:  Ceri Battle; Karen James; Paul Temblett
Journal:  J Intensive Care Soc       Date:  2014-12-09

5.  Characteristics and Outcomes of Intensive Care Unit Survivors: Experience of a Multidisciplinary Outpatient Clinic in a Teaching Hospital.

Authors:  Péricles A D Duarte; Jaquilene Barreto Costa; Silvana Trilo Duarte; Sheila Taba; Claudia Regina Felicetti Lordani; Erica Fernanda Osaku; Claudia Rejane Lima Macedo Costa; Dalas Cristina Miglioranza; Daniela Prochnow Gund; Amaury Cesar Jorge
Journal:  Clinics (Sao Paulo)       Date:  2017-12       Impact factor: 2.365

6.  Expressions of conflict following postoperative complications in older adults having major surgery.

Authors:  Elle L Kalbfell; Anne Buffington; Anna Kata; Karen J Brasel; Anne C Mosenthal; Zara Cooper; Emily Finlayson; Margaret L Schwarze
Journal:  Am J Surg       Date:  2021-06-15       Impact factor: 3.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.